This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...
About Relmada Therapeutics, Inc. Relmada is a clinical-stage biotechnology company focused on developing transformative therapies for oncology-related and central nervous system conditions. Its lead ...
The LGL Group, Inc. (NYSE American: LGL) (NYSE American: LGL WS) (“LGL Group” or the “Company”) today announced that its Board of Directors ...
Warrants to purchase 60,000 shares of common stock will be exercised at their existing exercise price of $2.00 per share, warrants to purchase 948,596 shares of common stock will be exercised at their ...
MultiSensor AI Holdings, Inc. (NASDAQ: MSAI) ("MSAI," "we," "our" or the "Company"), a pioneer in AI-powered industrial ...
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, announced today the ...
CompoSecure ( ($CMPO) ) has issued an announcement. On November 3, 2025, CompoSecure, Inc. announced the redemption of all its outstanding public ...
BIO-key® International, Inc. (NASDAQ: BKYI), an innovator in biometric authentication and Identity and Access Management (IAM ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from ...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the closing of its previously announced underwritten public offering of 28, ...
The proposed offering of the common stock described above is being offered by the Company pursuant to a "shelf" Registration Statement on Form S-3 (File No. 333-269178) filed with the Securities and ...
Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) ('Corbus” or the 'Company”), an oncology and obesity company, today ...